• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders

    KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Improving Taste and Mouthfeel of Plant-Based Protein Formulations

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements

    Improving Taste and Mouthfeel of Plant-Based Protein Formulations

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing

    BGG Receives Patent for Saw Palmetto ID Method
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Gaming and Esports Health Concerns

    Bioiberica’s DAOgest Authorized as Novel Food ingredient in EU
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BGG Americas, Inc.

    Gencor

    Botanic Healthcare LLC

    Verdure Sciences

    JRS Pharma
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    BGG Americas, Inc.

    Gencor

    Botanic Healthcare LLC

    Verdure Sciences

    JRS Pharma
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Pharmaceutical Oral Solids Market Update

    Pharmaceutical CDMOs continue to invest in oral solid dose development and manufacturing capabilities.

    Pharmaceutical Oral Solids Market Update
    By Tim Wright, Editor, Contract Pharma03.02.22
    Oral solids are cost-effective, easy to manufacture and patient-friendly, making them the most common dosage form in the pharmaceutical industry. In addition, advances in drug delivery technology, such as targeted drug delivery and sustained release dosage forms, are enabling oral solids to achieve even greater levels of bioavailability while reducing the frequency of drug administration. Other benefits exist in terms of relatively uncomplicated packaging needs and storage and distribution requirements due to chemical and physical stability.

    As the most preferred drug delivery form, oral solids are used across a wide spectrum of the pharmaceutical landscape. In fact, the small molecule outsourcing market is expected to reach $69.4 billion by 2024, with the demand being driven by complex molecules, according to Visiongain’s report, “Pharmaceutical Contract Manufacturing Market 2019-2029.”

    Over the past several months, contract development and manufacturing organizations (CDMOs) have continued to invest in and expand their oral solid dosage (OSD) development and manufacturing capabilities to meet the growing demands of the market. Some recent and notable examples follow.

    CordenPharma Acquires Three GMP Manufacturing Facilities
    CordenPharma, a full-service CDMO supplying APIs, excipients, drug products and associated packaging services, has completed the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in Portugal.

    The acquisition of the Vifor Pharma manufacturing sites expands CordenPharma’s capabilities and capacities in the manufacturing of non-sterile drug product dosage forms, including but not limited to, OSD forms such as tablets and capsules. With the addition of these three new facilities, CordenPharma’s global network now consists of 12 locations (11 GMP sites and one R&D laboratory), supported by more than 2,600 employees generating expected sales of over €800 million in 2022.

    Catalent Launches Xpress Pharmaceutics Service
    Catalent recently launched its new Xpress Pharmaceutics service, designed to accelerate the development of oral drugs through Phase 1 clinical studies. By integrating formulation development, on-demand clinical manufacturing, regulatory support and clinical testing, the approach can reduce both the cost and time taken to complete first-in-human trials, according to the CDMO.

    Xpress Pharmaceutics allows Catalent to work alongside innovator and clinical research organizations (CROs), and provide formulated clinical trial material with the necessary stability data that can be prepared for dosing patients at the clinical site, in line with adaptive study protocols. This approach provides a faster alternative to the traditional clinical development model, and offers the advantage of flexible dose and/or formulation composition adjustment during a clinical trial, guided by real-time clinical data.

    The service will be delivered by formulation development experts at Catalent’s facilities in Nottingham, UK and Beinheim, France and supported by the company’s global regulatory affairs team. To further support accelerated timelines, Catalent has a pre-qualified CRO partner, allowing seamless transition from manufacturing into clinical testing.

    Procaps Acquires First U.S. Softgel Production Facility
    Barranquilla, Colombia-based Procaps Group, an integrated international healthcare and pharmaceutical company, closed an asset purchase agreement to acquire an 86,000 square foot pharmaceutical production facility located in West Palm Beach, FL with production capacity of approximately 1.8 billion capsules per year for its iCDMO (integrated contract development and manufacturing organization) business unit, and is expected to increase the company’s product development capabilities by more than 70%.

    The soft gelatin capsule is a solid dosage form composed of two gelatin films that contain semisolid or liquid APIs protected by an external, hermetically sealed cover. Softgels are designed to deliver high precision dosage by achieving homogeneity of ingredients. The softgel capsules are well recognized in the supplement, over-the-counter (OTC) and the prescription market for improving patient adherence to the drug and therapy by facilitating swallowing due to the texture of its shell.

    The pharmaceutical production facility was purchased from Strides Pharma, a U.S. subsidiary of the Indian-based pharmaceutical corporation, the Strides Group. The facility is U.S. FDA approved and, in addition to the manufacturing capabilities, it offers development and analytical testing capacities, which the company says will become an important alternative for new pharmaceutical and OTC developments in highly regulated markets worldwide. Core assets included in the acquisition were several softgel encapsulation lines, new critical support systems, automated packaging line capabilities, as well as development facilities including pilot and scale up capabilities. Procaps Group expects the facility to begin operations in May of 2022.

    Eurofins CDMO Expands Spray Drying Capabilities
    Eurofins CDMO is expanding its spray dry development and production services in North America. The Canadian facility, located in Mississauga, Ontario, has expanded its cGMP spray drying capabilities with the addition of a GEA Mobile Minor spray drying system and dedicated 500 square foot clean room.

    With this expansion, Eurofins CDMO can further complement a broad range of services specializing in solubility enhancement for clinical development and small-scale commercial programs. Its process capabilities include solvent or aqueous systems, highly potent compounds, API and drug product development and manufacturing, solid state characterization, oral solid and inhalation dosage forms.

    The expansion of spray drying at Eurofins CDMO provides continued support of clinical development programs where formulation enabling is required for poorly soluble compounds. The new spray dry system enables manufacturing of solid dispersions at multi-kilo scale in support of a wide range of finished dosage forms for early clinical through to niche commercial programs.

    Piramal Strengthens North American Capabilities
    The CDMO Piramal Pharma Solutions has recently added development- and commercial-scale roller compaction technology to its Sellersville, PA drug product facility. The addition of the Gerteis Macro-pactor equipment, which is designed to handle both development and commercial scale roller compaction, enhances the site’s dry granulation and scale-up capabilities.


    Market data indicates that more than 20% of the new chemical entities being developed use roller compaction technology in their development and/or commercialization. In addition, roller compaction is an excellent technology for processing certain APIs, according to the company. The densification of dry blended powders is a critical capability that is required to handle products with poor API flow properties and instances where the API is moisture sensitive. Wet granulation is sometimes used to overcome these challenges, but many APIs are not amenable to wet granulation. In such cases, roller compaction provides a viable option to densify material and generate granules which can be further processed into capsules or tablets.

    The Gerteis Macro-pactor is a versatile piece of equipment, with the ability to handle 100-300 gram batches for small-scale development as well as larger volumes when used in continuous mode. It is recognized as an effective solution for both small-scale development requiring roller compaction technology and larger scale clinical and commercial batches as the compounds move forward in the development cycle.

    New CDMO Astrea Pharma Buys Recipharm Site
    A newly established CDMO, Astrea Pharma, focused on small molecule oral solid dosage forms, recently purchased Recipharm’s solid dose manufacturing site at Fontaine-lès-Dijon, France. Under Recipharm’s ownership, Fontaine has developed extensive experience manufacturing and packaging tablets and capsules. The capabilities fit well with Astrea’s ambitions to grow a broad range of different processing, filling and packaging technologies, as well as a wide geographical reach.

    Astrea’s owners are veterans in the CDMO industry and have the financial backing of the French long-term investment company Groupe Chevrillon, a family-owned business with a strong track record of investment in industrial and service companies.

    Metrics Contract Services Adds New Equipment
    Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has invested in additional equipment to enhance capacity in early phase drug development. Another Xcelodose 600S precision powder micro-dosing system will further provide capacity and efficiency improvements in meeting increasing demand for preclinical and early phase clinical GMP supply.

    Metrics’ new Xcelodose 600S is a strategic addition for Metrics’ formulation development team. The 600S can dispense dose weights as low as 100 micrograms, allowing for precise, accurate and repeated filling of capsules and other small dose containers without excipients or bulking agents. Most formulated products can also be filled without segregation. Metrics will install the new Xcelodose 600S in its state-of-the-art facility in Greenville, NC.

    Hovione Enters Dispersome Technology Partnership
    Hovione, a CDMO and provider of spray drying and particle engineering services, has entered a partnership with Zerion Pharma to market and commercialize Dispersome, Zerion´s proprietary solubility enhancement technology platform.

    Zerion’s technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions by spray drying. By combining Dispersome technology with Hovione’s spray drying capabilities, experience in development, scale-up and GMP manufacturing, the CDMO has strengthened its position in amorphous solid dispersions, coming up with innovative solutions to overcome a prevalent challenge faced by the industry: low drug solubility. 
    Related Searches
    • Contract Manufacturing
    • Delivery & Dosage Technologies
    Related Knowledge Center
    • Contract Manufacturing
    • Delivery & Dosage Technologies
    Suggested For You
    Soft Gel Technologies, Inc. Soft Gel Technologies, Inc.
    Ingredients By Nature Ingredients By Nature
    Trace Minerals Trace Minerals
    CAPTEK Softgel International CAPTEK Softgel International
    Foodarom Group Inc. Foodarom Group Inc.
    Windrose Partners LLC Windrose Partners LLC
    Automation Products, Inc. - Dynatrol Division Automation Products, Inc. - Dynatrol Division
    Dyna-Tabs, LLC Dyna-Tabs, LLC
    Alkemist Labs Now Conducts Heavy Metal, Pesticides Testing Alkemist Labs Now Conducts Heavy Metal, Pesticides Testing
    Kappa BioScience Forms Scientific and Medical Advisory Board Kappa BioScience Forms Scientific and Medical Advisory Board
    NPA Appoints Douglas Kalman, PhD, as Director of Scientific Affairs NPA Appoints Douglas Kalman, PhD, as Director of Scientific Affairs
    EccaTru™ - A New, Novel Source of Echinacea for Immune Support EccaTru™ - A New, Novel Source of Echinacea for Immune Support
    ConsumerLab Survey Reveals Trends in Supplement Usage Across 2021 ConsumerLab Survey Reveals Trends in Supplement Usage Across 2021
    Lallemand Probiotic Receives Health Claim Approval in Canada Lallemand Probiotic Receives Health Claim Approval in Canada
    Nutrasource Receives FDA ‘No Questions’ Letter on Howtian’s Sweetener Extract Nutrasource Receives FDA ‘No Questions’ Letter on Howtian’s Sweetener Extract

    Related Buyers Guide Companies

    • Soft Gel Technologies, Inc.

      ...
      Jeanette Fisher, Marketing Director 11.07.22

    • Ingredients By Nature

      ...
      Allie Mello, VP of Business Development and Operations 11.07.22

    • Minerals

      Trace Minerals

      ...
      Scott Boyson, VP of Public Relations 10.31.22


    • CAPTEK Softgel International

      ...
      Michael Betts, Marketing Director 10.25.22

    • Foodarom Group Inc.

      ...
      Noemie, Loiselle 10.12.22

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    • Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    • BGG Receives Patent for Saw Palmetto ID Method
    • Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    • Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Cellular Aging and Longevity: Ingredients for a New Age of Health
    • Addressing the Plastic-Packaging Problem: Getting to Zero-Waste with Zero Compromise
    • Moms Raise the Bar for Kids Supplements
    • Building on Steps to Improve Children’s Health Around the World
    • FDA Remains Focused on Modernizing DSHEA
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Coatings World

    Latest Breaking News From Coatings World

    Indorama Ventures and Carbios Reaffirm Partnership to Build PET Biorecycling Plant
    AkzoNobel Powder Coatings Enhances Digital Services with Launch of My Interpon Portal
    PPG Opens Color Creation Lab with Chery Automobile in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CardioRenal’s TENOR Device Receives Breakthrough Device Designation from FDA
    LifeQ Unveils New 24-Hour Sleep Solution
    Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Terran Biosciences, Pierre Fabre Ink Exclusive Licensing Deal for Idazoxan
    ASM Research Chemicals Launches Development Packs for API Manufacturing
    WuXi Increases Manufacturing Capacity in Germany
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    L'Oréal North Asia President Discusses China's Consumer Sector Recovery & Premium Beauty Trends
    Kiehl’s Celebrates Pride by Supporting The Trevor Project
    L’Oréal & UNESCO Announce 2023 Laureates of the For Women in Science International Awards
    Happi

    Latest Breaking News From Happi

    Olay Rolls Out Sensitive Skin Line
    World Taste & Smell Association's June 6 Webinar Looks at Smell and Multisensory Design
    Azelis Americas Opens New Application Labs for Personal Care, Home Care and Industrial Cleaning
    Ink World

    Latest Breaking News From Ink World

    Mactac Acquires Canadian Roll Label Distributor Label Supply
    WestRock Advances its Commitment to a Sustainable Future
    Roland DGA Announces Key Service Department Personnel Changes
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Schreiner's Pharma-Comb IL Label supports clinical trial cancer medication
    First Anytron ANY-JET III digital label press installed in Korea
    FPA announces Kasie Fairbarn as elected ELC co-chair
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Harper Hygienics Launches Hemp-Based Intimate Care Wipes
    What You’re Reading on Nonwovens-Industry.com
    Biodiapers Signs Agreement with Sicam
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Augmedics Debuts New Features, Indications for xvision Platform
    Artelon Closes $20M Series B Funding
    Orthofix Unveils Seven-Year Outcome Data for M6-C Artificial Cervical Disc
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    DIC Acquires Photoresist Polymers Manufacturer PCAS Canada
    Arkema Collaborates with Habitat for Humanity Philadelphia
    Vitesco Technologies, onsemi Sign SiC Long-Term Supply Agreement

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login